The Canadian experience with long term deflazacort treatment in Duchenne muscular dystrophy

Deflazacort is the most commonly prescribed corticosteroid for the treatment of Duchenne muscular dystrophy in Canada. We review the long term experience with deflazacort treatment at two centers in Canada; Montreal and Toronto. Deflazacort has benefitted both cohorts by prolonged ambulation, preser...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: McADAM, LAURA C., MAYO, AMANDA L., ALMAN, BENJAMIN A., BIGGAR, W. DOUGLAS
Format: Artigo
Idioma:Inglês
Publicat: Pacini Editore SpA 2012
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3440807/
https://ncbi.nlm.nih.gov/pubmed/22655512
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars